dialysis
-
Oak Street, Interwell Combine Primary Care & Dialysis with New Joint Venture
Oak Street Health teamed up with kidney care management company Interwell Health to create a joint venture called OakWell, which seeks to provide primary care to end-stage kidney disease patients directly in existing dialysis centers. End stage kidney disease patients spend upwards of 12 hours per week in dialysis centers — OakWell is meant to eliminate the barrier of attending separate, additional medical appointments.
-
MedCity Influencers, Policy, Opinion
Growing Nephrology Nursing Workforce Crisis Demands Policy Attention
It is critical for policymakers to work with nephology RNs to increase federal resources that will enable us to address burnout, decrease turnover rates, and build and support a stronger healthcare workforce nationwide.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Lessons learned from prison and dialysis while trying to prevent the pain, loss and cost of kidney diseases
These two health care settings provided invaluable lessons: get ahead of the curve through collaboration with other doctors, better monitoring, early referrals, and education.
-
The shift from community dialysis to ‘in-home’ treatments at skilled nursing facilities
The critical, pragmatic steps involved in developing patient-centric and equitable care for the nursing home patients came only very recently when medically advanced home hemodialysis therapies were repurposed and modified for use in the elderly frail nursing home dialysis patient populations
-
CSL shakes off pandemic woes, diversifies with $11.7B Vifor Pharma acquisition
CSL Limited makes many of its therapies from donated plasma, which posed a challenge as pandemic lockdowns led to a steep drop in plasma collections. In acquiring Vifor Pharma, CSL not only diversifies, it also expands its presence in the fast-growing nephrology market.
-
Devices & Diagnostics, MedCity Influencers
Saving lives, money & time: Moving away from center-based dialysis care
Virtually all routine dialysis should be available within skilled nursing and long term care facilities. The technology for this type of care exists and training LTC staff on easy to operate, portable dialysis devices should be the norm.
-
New CMS incentives look to close equity gap in home dialysis, kidney transplants
The agency issued a final rule on Friday that would update payment rates for dialysis. It includes a payment model that would incentivize healthcare providers to decrease disparities for in-home dialysis rates and transplant rates among low-income patients.
-
CMS grants quality reporting exceptions for facilities recovering from Hurricane Ida
The agency has granted certain Medicare quality reporting exceptions to healthcare facilities in areas of Louisiana, Mississippi, New York and New Jersey that were battered by Hurricane Ida. By providing the exceptions, CMS aims to enable facilities to direct their resources toward recovery.
-
Devices & Diagnostics, Health Tech
Impedimed device gets breakthrough designation for kidney failure
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
Startups, Health Services, Health Tech, Payers
Insurers back kidney care startup Cricket in $83.5M round
Cigna Ventures and Blue Shield of California contributed to a funding round for Cricket Health, a startup that provides services to help patients identify chronic kidney disease and get support in treatment. The investment was led by Valtruis, a firm that invests in value-based care companies.
-
Devices & Diagnostics, Health Tech
Portable dialysis company Outset Medical files for IPO
Outset Medical, a San Jose-based company making portable dialysis machines, filed the initial paperwork for an IPO. The company has not yet set a price range for its stock, but said it plans to raise roughly $100 million.
-
New CMS rule would add incentives for at-home dialysis
A proposed rule by the Centers for Medicare and Medicaid Services would expand payments for new dialysis machines when used at-home.
-
Health Services, Legal, Payers
Judge blocks California dialysis law
A federal judge blocked a bill that would have prevented dialysis clinics from steering patients to commercial insurance plans.
-
Devices & Diagnostics, Health Services, Health Tech
CVS launches clinical trial for at-home hemodialysis device
CVS Health’s new HemoCare device would open up the at-home market for hemodialysis, which uses an artificial kidney device to perform the procedure and has traditionally been difficult to provide outside of a clinical setting.